person Sign In / Create Account

Knowing Your Myeloma Therapy: BLENREP

Immunotherapy (CAR T, Bispecifics and more) Treatment Chapter

May 14, 2021 / 04:00PM - 05:00PM EDT

Watch Recording

Event Description

Name: Knowing Your Myeloma Therapy: BLENREP
Start: 2021-05-14T16:00:00-04:00
End: 2021-05-14T17:00:00-04:00

Join multiple myeloma specialist, Dr. Joshua Richter as he explains how BLENREP (belantamab mafodotin-blmf) is being used in the clinic, when to use it, what it can be used with, and how to properly manage side effects.

Schedule & Agenda

Introductions

04:00PM

Jenny Ahlstrom

Jenny welcomes everybody, shares the event agenda and introduces our featured speaker Dr. Joshua Richter.

04:00PM

Jenny Ahlstrom

Introductions

Jenny welcomes everybody, shares the event agenda and introduces our featured speaker Dr. Joshua Richter.

Presentation

04:05PM

Joshua Richter, MD

Dr. Richter explains how BLENREP is being used in the clinic, when to use it, what it can be used with, and how to properly manage side effects.

04:05PM

Joshua Richter, MD

Presentation

Dr. Richter explains how BLENREP is being used in the clinic, when to use it, what it can be used with, and how to properly manage side effects.

Question and Answer

04:40PM

Audience

Dr. Richter answers the audience's questions about his presentation, BLENREP, and other pertinent topics.

04:40PM

Audience

Question and Answer

Dr. Richter answers the audience's questions about his presentation, BLENREP, and other pertinent topics.

Speakers & Moderators

Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Joshua Richter, MD

Joshua Richter, MD, is Associate Professor of Medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology. He is the director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai. Dr. Richter treats patients with plasma cell dyscrasias, including multiple myeloma and related diseases such as AL amyloidosis, plasma cell leukemia, and Waldenstrom’s Macroglobulinemia. Dr. Richter has extensive experience with clinical trials focused on novel therapies, including antibody therapy and immunotherapy for a precision medicine approach. He has published extensively on these topics and has been invited to speak regionally, nationally, and also internationally. He has been published in journals such as the New England Journal of Medicine, Blood, and the Journal of Clinical Oncology.

Read Bio